Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Decreased Glomerular Filtration Rate is an Independent Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  • Published : 2011.04.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Patients with renal dysfunction (RD) experience worse prognosis after myocardial infarction (MI). The aim of the present study was to investigate the impact of admission estimated glomerular filtration rate (eGFR) on clinical outcomes of patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation MI (STEMI). Subjects and Methods: We retrospectively evaluated 4,542 eligible patients from the Korea Acute Myocardial Infarction Registry (KAMIR). Patients were divided into three groups according to eGFR (mL/min/1.73 $m^2$): normal renal function (RF) group (eGFR ${\geq}$60, n=3,515), moderate RD group (eGFR between 30 to 59, n=894) and severe RD group (eGFR <30, n=133). Baseline characteristics, angiographic and procedural results, and in-hospital outcomes between the three groups were compared. Results: Age, gender, Killip class ${\geq}$3, hypertension, diabetes, congestive heart failure, peak creatine kinase-MB, high sensitivity C-reactive protein, B-type natriuretic peptide, left ventricle ejection fraction, multivessel disease, infarct-related artery and rate of successful PCI were significantly different between the 3 groups (p<0.05). With decline in RF, in-hospital complications developed with an increasing frequency (14.1% vs. 31.8% vs. 45.5%, p<0.0001). In-hospital mortality rate was significantly higher in the moderate and severe RD groups as compared to the normal RF group (2.3% vs. 13.9% vs. 25.6%, p<0.0001). Using multivariate logistic regression analysis, adjusted odds ratio for in-hospital mortality was 2.67 {95% confidence interval (CI) 1.44-4.93, p=0.002} in the moderate RD group, and 4.09 (95% CI 1.48-11.28, p=0.006) in the severe RD group as compared to the normal RF group. Conclusion: Decreased admission eGFR was associated with worse clinical courses and it was an independent predictor of in-hospital mortality in STEMI patients undergoing primary PCI.

Keywords

References

  1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-305. https://doi.org/10.1056/NEJMoa041031
  2. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007;116:85-97. https://doi.org/10.1161/CIRCULATIONAHA.106.678342
  3. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39:1113-9. https://doi.org/10.1016/S0735-1097(02)01745-X
  4. Pinkau T, Mann JF, Ndrepepa G, et al. Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular out-comes. Am J Kidney Dis 2004;44:627-35. https://doi.org/10.1016/S0272-6386(04)00945-X
  5. Al Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002;106:974-80. https://doi.org/10.1161/01.CIR.0000027560.41358.B3
  6. Mielniczuk LM, Pfeffer MA, Lewis EF, et al. Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J 2008;155:725-31. https://doi.org/10.1016/j.ahj.2007.11.031
  7. Beattie JN, Soman SS, Sandber KR, et al. Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. Am J Kidney Dis 2001;37:1191-200. https://doi.org/10.1053/ajkd.2001.24522
  8. Wright RS, Reeder GS, Herzog CA, et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002;137:563-70. https://doi.org/10.7326/0003-4819-137-7-200210010-00007
  9. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McMClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002;137:555-62. https://doi.org/10.7326/0003-4819-137-7-200210010-00006
  10. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8. https://doi.org/10.1001/jama.1997.03550230069040
  11. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999;341:1413-9. https://doi.org/10.1056/NEJM199911043411901
  12. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20. https://doi.org/10.1016/S0140-6736(03)12113-7
  13. Yamaguchi J, Kasanuki H, Ishii Y, et al. Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). Am J Cardiol 2004;93: 1526-8. https://doi.org/10.1016/j.amjcard.2004.02.065
  14. Ferrer-Hita JJ, Dominguez-Rodriguez A, Garcia-Gonzalez MJ, Abreu-Gonzalez P. Renal dysfunction is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Int J Cardiol 2007;118:243-5. https://doi.org/10.1016/j.ijcard.2006.06.044
  15. Marenzi G, Moltrasio M, Assanelli E, et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 2007;153:755-62. https://doi.org/10.1016/j.ahj.2007.02.018
  16. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
  17. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-83. https://doi.org/10.1056/NEJMra054415
  18. Sorensen CR, Brendorp B, Rask-Madsen C, Kober L, Kjoller E, Torp-Pedersen C. The prognostic importance of creatinine clearance after acute myocardial infarction. Eur Heart J 2002;23:948-52. https://doi.org/10.1053/euhj.2001.2989
  19. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003;108:2769-75. https://doi.org/10.1161/01.CIR.0000103623.63687.21
  20. Namgung J, Doh JH, Lee SY, Huh WS, Park SW, Lee WR. Effect of N-acetylcysteine in prevention of contrast-induced nephropathy after coronary angiography. Korean Circ J 2005;35:696-701. https://doi.org/10.4070/kcj.2005.35.9.696
  21. Hirakawa Y, Masuda Y, Kuzuya M, Iguchi A, Kimata T, Uemura K. Association of renal insufficiency with in-hospital mortality in Japanese patients with acute myocardial infarction undergoing percutaneous coronary interventions. Int Heart J 2006;47:745-52. https://doi.org/10.1536/ihj.47.745
  22. Gibson CM, Pinto DS, Murphy SA, et al. Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. J Am Coll Cardiol 2003;42:1535-43. https://doi.org/10.1016/j.jacc.2003.06.001
  23. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004;351:1285-95. https://doi.org/10.1056/NEJMoa041365
  24. Lee KH, Jeong MH, Ahn YK, et al. Sex differences of the clinical characteristics and early management in the Korea acute myocardial infarction registry. Korean Circ J 2007;37:64-71. https://doi.org/10.4070/kcj.2007.37.2.64
  25. Parikh CR, Coca SG, Wang Y, Masoudi FA, Krumholz HM. Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med 2008;168:987-95. https://doi.org/10.1001/archinte.168.9.987
  26. Medi C, Montalescot G, Budaj A, et al. Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). JACC Cardiovasc Interv 2009;2:26-33. https://doi.org/10.1016/j.jcin.2008.09.010
  27. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002; 144:226-32. https://doi.org/10.1067/mhj.2002.125513
  28. Berger AK, Duval S, Krumholz HM. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. J Am Coll Cardiol 2003;42:201-8. https://doi.org/10.1016/S0735-1097(03)00572-2
  29. Lee KH, Lee SR, Kang KP, et al. Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients. Korean Circ J 2010;40:68-73. https://doi.org/10.4070/kcj.2010.40.2.68
  30. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial. J Am Coll Cardiol 2007;49:1362-8. https://doi.org/10.1016/j.jacc.2007.02.027

Cited by

  1. Renal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry vol.14, pp.1, 2011, https://doi.org/10.1186/1471-2369-14-62
  2. Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study vol.15, pp.None, 2011, https://doi.org/10.1186/s12872-015-0174-2
  3. Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction : vol.16, pp.11, 2011, https://doi.org/10.2459/jcm.0000000000000238
  4. The Impact of Admission Serum Creatinine Derived Estimated Glomerular Filtration Rate on Major Adverse Cardiac Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutan vol.8, pp.4, 2011, https://doi.org/10.14740/jocmr2482w
  5. The Impact of Admission Serum Creatinine on Major Adverse Clinical Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention vol.9, pp.2, 2018, https://doi.org/10.14740/cr689w
  6. Model for End-Stage Liver Disease Score Predicts the Mortality of Patients with Coronary Heart Disease Who Underwent Percutaneous Coronary Intervention vol.2021, pp.None, 2011, https://doi.org/10.1155/2021/6401092